Article Text

Download PDFPDF

Treating rheumatoid arthritis to target: the patient version of the international recommendations
  1. M P T de Wit1,
  2. J S Smolen2,3,
  3. L Gossec4,
  4. D M F M van der Heijde5
  1. 1Department of Medical Humanities, VU Medical Centre, Amsterdam, The Netherlands
  2. 2Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria
  3. 32nd Department of Medicine, Hietzing Hospital, Vienna, Austria
  4. 4Rheumatology B Department, Paris Descartes University, Cochin Hospital, Paris, France
  5. 5Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  1. Correspondence to M P T de Wit, Department Medical Humanities, VU Medical Centre, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands; mp.dewit{at}vumc.nl

Abstract

To transcribe the treat-to-target (T2T) recommendations into a version that can be easily understood by patients. A core group of physicians and patients involved in the elaboration of the T2T recommendations produced a draft version of the T2T recommendations in lay language. This version was discussed, changed and reworded during a 1-day meeting with nine patients with rheumatoid arthritis (RA) from nine different European countries. Finally, the level of agreement with the translation and with the content of the recommendations was assessed by the patient participants. The project resulted in a patient version of the T2T recommendations. The level of agreement with the translation and the content was high. The group discussion revealed a number of potential barriers for the implementation of the recommendations in clinical practice, such as inequalities in arthritis healthcare provision across Europe. An accurate version of the T2T recommendations that can be easily understood by patients is available and can improve the shared decision process in the management of RA.

This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests This project was supported by an unrestricted educational grant from Abbott Immunology. Abbott affiliates were not involved in the programme or voting.

  • Provenance and peer review Not commissioned; externally peer reviewed.